Global Cell Therapy Manufacturing Market Research Report 2022

Publisher Name :
Date: 22-Sep-2022
No. of pages: 112
Inquire Before Buying

This report aims to provide a comprehensive presentation of the global market for Cell Therapy Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy Manufacturing.

The Cell Therapy Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cell Therapy Manufacturing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Merck KGaA

- Avantor

- Cell Therapies

- Thermo Fisher Scientific

- Charles River Laboratories

- Catalent

- Bio-Techne

- Cytiva

- Lonza

- The Discovery Labs

- BIOCENTRIQ

- FUJIFILM Diosynth Biotechnologies

- Novartis AG

- Bristol-Myers Squibb

- Gilead Sciences

- WuXi AppTec

- OXGENE

- Pharmaron

- Aldevron

- FLODESIGN SONICS

- Exothera

Product Type Insights

Global markets are presented by Cell Therapy Manufacturing type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Cell Therapy Manufacturing are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Cell Therapy Manufacturing segment by Type

- Autologous

- Allogenic

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Cell Therapy Manufacturing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cell Therapy Manufacturing market.

Cell Therapy Manufacturing Segment by Application

- HIV

- Autoimmune Disorders

- Immune Deficiencies

- Cancer

- Neurological Disorders

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Cell Therapy Manufacturing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Cell Therapy Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cell Therapy Manufacturing industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy Manufacturing.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cell Therapy Manufacturing companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Cell Therapy Manufacturing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Autologous
1.2.3 Allogenic
1.3 Market by Application
1.3.1 Global Cell Therapy Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 HIV
1.3.3 Autoimmune Disorders
1.3.4 Immune Deficiencies
1.3.5 Cancer
1.3.6 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Manufacturing Market Perspective (2017-2028)
2.2 Cell Therapy Manufacturing Growth Trends by Region
2.2.1 Cell Therapy Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Therapy Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Cell Therapy Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Cell Therapy Manufacturing Market Dynamics
2.3.1 Cell Therapy Manufacturing Industry Trends
2.3.2 Cell Therapy Manufacturing Market Drivers
2.3.3 Cell Therapy Manufacturing Market Challenges
2.3.4 Cell Therapy Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Manufacturing Players by Revenue
3.1.1 Global Top Cell Therapy Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Cell Therapy Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy Manufacturing Revenue
3.4 Global Cell Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Cell Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Manufacturing Revenue in 2021
3.5 Cell Therapy Manufacturing Key Players Head office and Area Served
3.6 Key Players Cell Therapy Manufacturing Product Solution and Service
3.7 Date of Enter into Cell Therapy Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Manufacturing Breakdown Data by Type
4.1 Global Cell Therapy Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Cell Therapy Manufacturing Forecasted Market Size by Type (2023-2028)
5 Cell Therapy Manufacturing Breakdown Data by Application
5.1 Global Cell Therapy Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Cell Therapy Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Therapy Manufacturing Market Size (2017-2028)
6.2 North America Cell Therapy Manufacturing Market Size by Country (2017-2022)
6.3 North America Cell Therapy Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Therapy Manufacturing Market Size (2017-2028)
7.2 Europe Cell Therapy Manufacturing Market Size by Country (2017-2022)
7.3 Europe Cell Therapy Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Cell Therapy Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Therapy Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Therapy Manufacturing Market Size (2017-2028)
9.2 Latin America Cell Therapy Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Cell Therapy Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Cell Therapy Manufacturing Introduction
11.1.4 Merck KGaA Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.1.5 Merck KGaA Recent Development
11.2 Avantor
11.2.1 Avantor Company Detail
11.2.2 Avantor Business Overview
11.2.3 Avantor Cell Therapy Manufacturing Introduction
11.2.4 Avantor Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.2.5 Avantor Recent Development
11.3 Cell Therapies
11.3.1 Cell Therapies Company Detail
11.3.2 Cell Therapies Business Overview
11.3.3 Cell Therapies Cell Therapy Manufacturing Introduction
11.3.4 Cell Therapies Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.3.5 Cell Therapies Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Detail
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Cell Therapy Manufacturing Introduction
11.5.4 Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.5.5 Charles River Laboratories Recent Development
11.6 Catalent
11.6.1 Catalent Company Detail
11.6.2 Catalent Business Overview
11.6.3 Catalent Cell Therapy Manufacturing Introduction
11.6.4 Catalent Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.6.5 Catalent Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Company Detail
11.7.2 Bio-Techne Business Overview
11.7.3 Bio-Techne Cell Therapy Manufacturing Introduction
11.7.4 Bio-Techne Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.7.5 Bio-Techne Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Detail
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Cell Therapy Manufacturing Introduction
11.8.4 Cytiva Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.8.5 Cytiva Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Cell Therapy Manufacturing Introduction
11.9.4 Lonza Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.9.5 Lonza Recent Development
11.10 The Discovery Labs
11.10.1 The Discovery Labs Company Detail
11.10.2 The Discovery Labs Business Overview
11.10.3 The Discovery Labs Cell Therapy Manufacturing Introduction
11.10.4 The Discovery Labs Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.10.5 The Discovery Labs Recent Development
11.11 BIOCENTRIQ
11.11.1 BIOCENTRIQ Company Detail
11.11.2 BIOCENTRIQ Business Overview
11.11.3 BIOCENTRIQ Cell Therapy Manufacturing Introduction
11.11.4 BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.11.5 BIOCENTRIQ Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Detail
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Cell Therapy Manufacturing Introduction
11.13.4 Novartis AG Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.13.5 Novartis AG Recent Development
11.14 Bristol-Myers Squibb
11.14.1 Bristol-Myers Squibb Company Detail
11.14.2 Bristol-Myers Squibb Business Overview
11.14.3 Bristol-Myers Squibb Cell Therapy Manufacturing Introduction
11.14.4 Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.14.5 Bristol-Myers Squibb Recent Development
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Detail
11.15.2 Gilead Sciences Business Overview
11.15.3 Gilead Sciences Cell Therapy Manufacturing Introduction
11.15.4 Gilead Sciences Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.15.5 Gilead Sciences Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Detail
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Cell Therapy Manufacturing Introduction
11.16.4 WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.16.5 WuXi AppTec Recent Development
11.17 OXGENE
11.17.1 OXGENE Company Detail
11.17.2 OXGENE Business Overview
11.17.3 OXGENE Cell Therapy Manufacturing Introduction
11.17.4 OXGENE Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.17.5 OXGENE Recent Development
11.18 Pharmaron
11.18.1 Pharmaron Company Detail
11.18.2 Pharmaron Business Overview
11.18.3 Pharmaron Cell Therapy Manufacturing Introduction
11.18.4 Pharmaron Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.18.5 Pharmaron Recent Development
11.19 Aldevron
11.19.1 Aldevron Company Detail
11.19.2 Aldevron Business Overview
11.19.3 Aldevron Cell Therapy Manufacturing Introduction
11.19.4 Aldevron Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.19.5 Aldevron Recent Development
11.20 FLODESIGN SONICS
11.20.1 FLODESIGN SONICS Company Detail
11.20.2 FLODESIGN SONICS Business Overview
11.20.3 FLODESIGN SONICS Cell Therapy Manufacturing Introduction
11.20.4 FLODESIGN SONICS Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.20.5 FLODESIGN SONICS Recent Development
11.21 Exothera
11.21.1 Exothera Company Detail
11.21.2 Exothera Business Overview
11.21.3 Exothera Cell Therapy Manufacturing Introduction
11.21.4 Exothera Revenue in Cell Therapy Manufacturing Business (2017-2022)
11.21.5 Exothera Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell Therapy Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Autologous
Table 3. Key Players of Allogenic
Table 4. Global Cell Therapy Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cell Therapy Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cell Therapy Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cell Therapy Manufacturing Market Share by Region (2017-2022)
Table 8. Global Cell Therapy Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cell Therapy Manufacturing Market Share by Region (2023-2028)
Table 10. Cell Therapy Manufacturing Market Trends
Table 11. Cell Therapy Manufacturing Market Drivers
Table 12. Cell Therapy Manufacturing Market Challenges
Table 13. Cell Therapy Manufacturing Market Restraints
Table 14. Global Cell Therapy Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cell Therapy Manufacturing Market Share by Players (2017-2022)
Table 16. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2021)
Table 17. Ranking of Global Top Cell Therapy Manufacturing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cell Therapy Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy Manufacturing Product Solution and Service
Table 21. Date of Enter into Cell Therapy Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cell Therapy Manufacturing Revenue Market Share by Type (2017-2022)
Table 25. Global Cell Therapy Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cell Therapy Manufacturing Revenue Market Share by Type (2023-2028)
Table 27. Global Cell Therapy Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cell Therapy Manufacturing Revenue Market Share by Application (2017-2022)
Table 29. Global Cell Therapy Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cell Therapy Manufacturing Revenue Market Share by Application (2023-2028)
Table 31. North America Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Merck KGaA Company Detail
Table 42. Merck KGaA Business Overview
Table 43. Merck KGaA Cell Therapy Manufacturing Product
Table 44. Merck KGaA Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 45. Merck KGaA Recent Development
Table 46. Avantor Company Detail
Table 47. Avantor Business Overview
Table 48. Avantor Cell Therapy Manufacturing Product
Table 49. Avantor Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 50. Avantor Recent Development
Table 51. Cell Therapies Company Detail
Table 52. Cell Therapies Business Overview
Table 53. Cell Therapies Cell Therapy Manufacturing Product
Table 54. Cell Therapies Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 55. Cell Therapies Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Cell Therapy Manufacturing Product
Table 59. Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Charles River Laboratories Company Detail
Table 62. Charles River Laboratories Business Overview
Table 63. Charles River Laboratories Cell Therapy Manufacturing Product
Table 64. Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 65. Charles River Laboratories Recent Development
Table 66. Catalent Company Detail
Table 67. Catalent Business Overview
Table 68. Catalent Cell Therapy Manufacturing Product
Table 69. Catalent Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Catalent Recent Development
Table 71. Bio-Techne Company Detail
Table 72. Bio-Techne Business Overview
Table 73. Bio-Techne Cell Therapy Manufacturing Product
Table 74. Bio-Techne Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Bio-Techne Recent Development
Table 76. Cytiva Company Detail
Table 77. Cytiva Business Overview
Table 78. Cytiva Cell Therapy Manufacturing Product
Table 79. Cytiva Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Cytiva Recent Development
Table 81. Lonza Company Detail
Table 82. Lonza Business Overview
Table 83. Lonza Cell Therapy Manufacturing Product
Table 84. Lonza Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Lonza Recent Development
Table 86. The Discovery Labs Company Detail
Table 87. The Discovery Labs Business Overview
Table 88. The Discovery Labs Cell Therapy Manufacturing Product
Table 89. The Discovery Labs Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 90. The Discovery Labs Recent Development
Table 91. BIOCENTRIQ Company Detail
Table 92. BIOCENTRIQ Business Overview
Table 93. BIOCENTRIQ Cell Therapy ManufacturingProduct
Table 94. BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 95. BIOCENTRIQ Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies Company Detail
Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies Cell Therapy ManufacturingProduct
Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 100. FUJIFILM Diosynth Biotechnologies Recent Development
Table 101. Novartis AG Company Detail
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Cell Therapy ManufacturingProduct
Table 104. Novartis AG Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 105. Novartis AG Recent Development
Table 106. Bristol-Myers Squibb Company Detail
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Cell Therapy ManufacturingProduct
Table 109. Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Gilead Sciences Company Detail
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Cell Therapy ManufacturingProduct
Table 114. Gilead Sciences Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. WuXi AppTec Company Detail
Table 117. WuXi AppTec Business Overview
Table 118. WuXi AppTec Cell Therapy ManufacturingProduct
Table 119. WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 120. WuXi AppTec Recent Development
Table 121. OXGENE Company Detail
Table 122. OXGENE Business Overview
Table 123. OXGENE Cell Therapy ManufacturingProduct
Table 124. OXGENE Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 125. OXGENE Recent Development
Table 126. Pharmaron Company Detail
Table 127. Pharmaron Business Overview
Table 128. Pharmaron Cell Therapy ManufacturingProduct
Table 129. Pharmaron Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 130. Pharmaron Recent Development
Table 131. Aldevron Company Detail
Table 132. Aldevron Business Overview
Table 133. Aldevron Cell Therapy ManufacturingProduct
Table 134. Aldevron Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 135. Aldevron Recent Development
Table 136. FLODESIGN SONICS Company Detail
Table 137. FLODESIGN SONICS Business Overview
Table 138. FLODESIGN SONICS Cell Therapy ManufacturingProduct
Table 139. FLODESIGN SONICS Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 140. FLODESIGN SONICS Recent Development
Table 141. Exothera Company Detail
Table 142. Exothera Business Overview
Table 143. Exothera Cell Therapy ManufacturingProduct
Table 144. Exothera Revenue in Cell Therapy Manufacturing Business (2017-2022) & (US$ Million)
Table 145. Exothera Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Autologous Features
Figure 3. Allogenic Features
Figure 4. Global Cell Therapy Manufacturing Market Share by Application in 2021 & 2028
Figure 5. HIV Case Studies
Figure 6. Autoimmune Disorders Case Studies
Figure 7. Immune Deficiencies Case Studies
Figure 8. Cancer Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cell Therapy Manufacturing Report Years Considered
Figure 11. Global Cell Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell Therapy Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell Therapy Manufacturing Market Share by Region: 2021 VS 2028
Figure 14. Global Cell Therapy Manufacturing Market Share by Players in 2021
Figure 15. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy Manufacturing Revenue in 2021
Figure 17. North America Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 19. United States Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 23. Germany Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2017-2028)
Figure 31. China Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 39. Mexico Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy Manufacturing Market Share by Country (2017-2028)
Figure 43. Turkey Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Merck KGaA Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 46. Avantor Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 47. Cell Therapies Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 49. Charles River Laboratories Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 50. Catalent Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 51. Bio-Techne Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 52. Cytiva Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 53. Lonza Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 54. The Discovery Labs Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 55. BIOCENTRIQ Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 57. Novartis AG Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 59. Gilead Sciences Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 60. WuXi AppTec Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 61. OXGENE Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 62. Pharmaron Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 63. Aldevron Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 64. FLODESIGN SONICS Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 65. Exothera Revenue Growth Rate in Cell Therapy Manufacturing Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Clear Aligner Market: Analysis By Treatment Cases, By Procedure (Doctor-Directed, and Direct-to-Consumer), By Age Group (Adult and Teen), By End-User (Standalone, Group Practices, Hospitals, and Other End-User), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
    Published: 30-Sep-2022        Price: US 2450 Onwards        Pages: 190
    The global clear aligner market was valued at US$3.98 billion in 2021. The market value is expected to reach US$13.13 billion by 2027. Clear aligners are orthodontic devices that are transparent, plastic forms of dental braces used to adjust teeth. Clear aligners are a new alternative to traditional metal braces. They’re made of clear, thin plastic that goes over the teeth and gradually shifts them into place. The factors such as the growing patient population suffering from mal......
  • Global Neonatal (Preterm) Infant Care Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 108
    Neonatal (preterm) infant care forms a significant part of the pediatric healthcare market in the global as neonatal (preterm) births are one of the leading causes of infant mortality in the worldwide. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neonatal (Preterm) Infant Care market is projected to reach US$ 3330.8 million by 2028 from an estimated US$ 2402 million in 2022, at a CAGR of 5.6% during 2023 and 2028.......
  • Global Neurorehabilitation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Neurorehabilitation market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. China Neurorehabilitation market size was US$ million in 2021, while the US and Europe Neurorehabilitation were US$ million and US$ million, severally. The proportion of the US was % in 2021, while China and Europe were % and % respectiv......
  • Global Personal Emergency Response Systems (PERS) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 122
    Personal emergency response system (PERS) is designed to signal the presence of a hazard and the requirement of urgent attention for the older population as well as people with disabilities during an emergency. Medical personnel are dispatched by response associates to assist the affected people accordingly for further care. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Personal Emergency Response Systems (PERS) mark......
  • Global Nitric Oxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 81
    Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Nitric Oxide market is projected t......
  • Global Lumpectomy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 118
    Women who've been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy). A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure,......
  • Global Medical Laser Marking Machine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 118
    Laser marking machine is a type of machine that use laser beam to make permanent marking in various surface materials. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Medical Laser Marking Machine market is projected to reach US$ 382.5 million by 2028 from an estimated US$ 218.3 million in 2022, at a CAGR of 9.8% during 2023 and 2028. The top 10 companies had a combined market share of 56% of the global total in......
  • Global Plastic Injection Molding for Medical Device Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 138
    Plastic injection molding is an extremely versatile method of mass production, and it has numerous benefits that make it an invaluable tool for creating working prototypes at scale. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Plastic Injection Molding for Medical Device market is projected to reach US$ 46780 million by 2028 from an estimated US$ 34910 million in 2022, at a CAGR of 5.0% during 2023 and 2028. ......
  • Global SPECT and SPECT-CT Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 101
    Using specialized detector crystals that emit light when hit by photons (radiation emanating from the body) we are able to plot their origin on a grid or matrix using intricate x- y- coordinate circuitry that ultimately allows us to reconstruct the physiological and pathological processes taking place in the body pictographically by coupling radioactive isotopes to specific drugs, chemicals and molecules and administering them. Highlights Considering the economic change due......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs